Christine Mikail Cvijic

CFO

Insider activity · 24 months1 buy6 salesCumulative net flow

Nov 24 · 1 buy · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 1 saleApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 1 saleMar 26 · 0 buys · 2 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 2 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€469k

▼ Sales (8 ops.)

€445k

Latest filing published 07 Jul 2026 for Neurogene Inc., €19k.

Filing timeline

BuySale

Christine Mikail Cvijic

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Neurogene Inc. 1 purchase · last 25 Nov 2024

Since each purchase

Neurogene Inc.
Filed 25 Nov 2024 · 698 days ago · €469k
-21.9%
Entry US$26.87 · Close at T+365 US$20.99

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Christine Mikail Cvijic: trading record in brief

Christine Mikail Cvijic has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Neurogene Inc. and Dendreon Corp. Over a trading history stretching from 8 March 2012 to 7 July 2026, the count stands at 22 filings.

The open-market side counts 1 purchase for €469k alongside 8 sales for €445k. Netting one side against the other leaves €25k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 13 share grants. So far in 2026, the count stands at no purchases and 7 sales.

The newest entry dates from 7 July 2026: an open-market sale of €19k, in Neurogene Inc. The last purchase on record was published on 25 November 2024, which is 698 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.